Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EnCoRe MoMS Aim 3: Engaging Communities to Reduce Morbidity From Maternal Sepsis

NCT06160349 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06160349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06160349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EnCoRe MoMS Aim 3: Engaging Communities to Reduce Morbidity From Maternal Sepsis
Lead sponsor
Columbia University
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 20, 2023
Completion date
September 30, 2026
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infections, maternal sepsis